These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8697843)

  • 1. The cost of treating COPD patients with long-term oxygen therapy in a French population.
    Pelletier-Fleury N; Lanoe JL; Fleury B; Fardeau M
    Chest; 1996 Aug; 110(2):411-6. PubMed ID: 8697843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cost-effectiveness study of 2 long-term home oxygen therapy management systems].
    Pelletier-Fleury N; Lanoë JL; Fleury B; Fardeau M
    Rev Epidemiol Sante Publique; 1997 Mar; 45(1):53-63. PubMed ID: 9173459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacoeconomic evaluation of COPD.
    Hilleman DE; Dewan N; Malesker M; Friedman M
    Chest; 2000 Nov; 118(5):1278-85. PubMed ID: 11083675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Costs of chronic obstructive pulmonary disease in patients treated in ambulatory care in Poland].
    Jahnz-Różyk K; Targowski T; From S; Faluta T; Borowiec L
    Pneumonol Alergol Pol; 2011; 79(5):337-42. PubMed ID: 21861257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors in COPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressure.
    Oswald-Mammosser M; Weitzenblum E; Quoix E; Moser G; Chaouat A; Charpentier C; Kessler R
    Chest; 1995 May; 107(5):1193-8. PubMed ID: 7750305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost analysis of chronic obstructive pulmonary disease in a tertiary care setting in Taiwan.
    Chiang CH
    Respirology; 2008 Sep; 13(5):689-94. PubMed ID: 18513247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The demographics and economics of long-term oxygen therapy.
    Dunne PJ
    Respir Care; 2000 Feb; 45(2):223-8; discussion 228-30. PubMed ID: 10771794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of outpatient and inpatient costs of moderate and severe exacerbations of chronic obstructive pulmonary disease in Poland].
    Jahnz-Rózyk K; Targowski T; From S
    Pneumonol Alergol Pol; 2008; 76(6):426-31. PubMed ID: 19173191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of a hospital-based home-care program on the management of COPD patients receiving long-term oxygen therapy.
    Farrero E; Escarrabill J; Prats E; Maderal M; Manresa F
    Chest; 2001 Feb; 119(2):364-9. PubMed ID: 11171710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term oxygen therapy at home. Compliance with medical prescription and effective use of therapy. ANTADIR Working Group on Oxygen Therapy. Association Nationale de Traitement à Domicile des Insuffisants Respiratories.
    Pépin JL; Barjhoux CE; Deschaux C; Brambilla C
    Chest; 1996 May; 109(5):1144-50. PubMed ID: 8625658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of health-care costs in patients with chronic obstructive pulmonary disease using lightweight portable oxygen systems versus traditional compressed-oxygen systems.
    Mapel DW; Robinson SB; Lydick E
    Respir Care; 2008 Sep; 53(9):1169-75. PubMed ID: 18718034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic factors in survival of patients with obstructive respiratory insufficiency treated by long-term oxygen therapy. Data from the ANTADIR registry].
    Chailleux E; Binet F; Sadoul P
    Rev Mal Respir; 1992; 9(6):603-11. PubMed ID: 1470752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of nurse home visits on compliance to long-term oxygen therapy. 14 months follow-up].
    Nasiłowski J; Przybyłowski T; Klimiuk J; Leśkow A; Orska K; Chazan R
    Pneumonol Alergol Pol; 2009; 77(4):363-70. PubMed ID: 19722141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reevaluation of continuous oxygen therapy after initial prescription in patients with chronic obstructive pulmonary disease.
    Oba Y; Salzman GA; Willsie SK
    Respir Care; 2000 Apr; 45(4):401-6. PubMed ID: 10780035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospitalization Due to Co-Morbid Conditions is the Main Cost Driver Among Subjects With COPD-A Report From the Population-Based OLIN COPD Study.
    Jansson SA; Backman H; Rönmark E; Lundbäck B; Lindberg A
    COPD; 2015 Aug; 12(4):381-9. PubMed ID: 25415366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Home care of severe COPD].
    Muir JF; Cuvelier A
    Rev Prat; 1995 May; 45(10):1251-6. PubMed ID: 7659970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative study of health care costs for patients using home oxygen therapy or those in waiting lists].
    Maquilón C; Chiong H; Bello S; Naranjo C; Lira P; Díaz M
    Rev Med Chil; 2001 Dec; 129(12):1395-403. PubMed ID: 12080877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term home oxygen therapy in children and adolescents: analysis of clinical use and costs of a home care program.
    Munhoz AS; Adde FV; Nakaie CM; Doria Filho U; Silva Filho LV; Rodrigues JC
    J Pediatr (Rio J); 2011; 87(1):13-8. PubMed ID: 21180778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The continuing impact of home oxygen therapy for respiratory patients on a hospital budget.
    Crockett A; Moss J; Alpers J
    Aust Health Rev; 1992; 15(3):259-68. PubMed ID: 10121778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of oxygen therapy on increasing arterial oxygen tension in hypoxemic patients with stable chronic obstructive pulmonary disease while breathing ambient air.
    O'Donohue WJ
    Chest; 1991 Oct; 100(4):968-72. PubMed ID: 1914613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.